In 2007, Brychem carried out a market survey of the world's chemical, fine chemical and speciality chemical industries and their interconnections for an Asian chemical company that needed to develop a better perspective of where new opportunities might be found. This experience led to several similar reviews of the many industry sectors.

Undertook a review of the demand, the manufacturers and process technologies used to make the world's most important antiretroviral drugs. This entailed many plant visits to Indian and Chinese producers.

Pre-due and due-diligence studies on several agrochemical companies and one major European group have been undertaken for companies looking to make acquisitions in the multibillion dollar range.

Detailed reviews of the producers, manufacturing processes and the cost economics of glyphosate have been undertaken for several companies, each with differing interests in the results. This has provided Brychem with an unusually well-informed understanding of the world's bigest selling agrochemical. To date, some twenty studies have been undertaken.

Brychem's unusual background in the manufacture and sale of prostaglandins, peptides, amino acids and controlled drugs (CPS, morphine, codeine, hydromorphone, buprenorphine and several others) has enabled it to carry out many projects in these difficult areas.

Retained on a long term basis by an Asian fine chemical R&D group to identify pharmaceutical intermediates for development and introduce the company to potential customers.

Carried out a review of L-lactic acid for a major Japanese company in order to assist in its assessment of its investment potential.

Detailed market studies for the production of a number of bulk actives (APIs) have been undertaken over the years. Examples of detailed techno-economic studies undertaken include those of alprostadil, captopril, ibuprofen, omeprazole, paroxetine, latanoprost, lamivudine and zidovudine, ACE-inhibitors in China and India, cimetidine in Japan and China, ranitidine in India, Chinese markets for interferons.

Brychem has carried out many studies in the area of chiral chemistry, usually helping companies identify markets for their technologies. These assessments have included all types of chemistry that lead to a homochiral product.

Evaluation of the production and applications of a number of fluorinated fine chemicals being used in a range of different end-use industries for several different companies over the years.

Assisted a number of European biotech (emerging pharma) companies in managing their chemical outsourcing activities, including acting as an interim project manager.

Worldwide review of the producers and manufacturing processes of the six high performance sweeteners sold in Europe. Companies in Europe, Asia and the USA were visited.